NRXP/ 08/07/2026 · 9:53 AM FDA Completes First-Cycle Review of NRx’s Ketamine ANDA with No Drug-Related Issues FDA clears path for NRx’s preservative-free ketamine: no major drug issues found, only packaging certification remains.
